Vandria Closes Series a Round at CHF28.3m
Hevolution FoundationHevolution Foundation and Dolby Family Ventures led Vandria’s Series A closing, bringing the capital to CHF 28.3. With the money, the 2021 EFPL spin-out aims to advance its first in class mitophagy inducer VNA-318 that targets several neurodegenerative indications into clinical development.